United States Biotechnology & Medical Research

Alnylam Pharmaceuticals Inc (ALNY)

Alnylam Pharmaceuticals experienced net selling activity over the past ninety days, totaling approximately 398,855 dollars. Executive Bryan Supran executed these disposals. Despite a recent 24.7 percent decline in share value, the firm reported strong results financiers, significantly beating earnings expectations during the latest period.
Ticker: ALNY Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Alnylam Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
SUPRAN BRYAN EVP, CLO and Secretary Officer
Transaction date
Sale
Price
264.69
Quantity 25,746 -10.2%
Value US$58,201
SUPRAN BRYAN Officer Officer
Transaction date
Proposed sale
Price
150.87
Quantity 29,670
Value US$1,868,728
3.0
PYOTT DAVID E I Non-Executive Director
Transaction date
Planned sale
Price
35.03
Quantity 7,156 -10.0%
Value US$3,787,316
3.0
PYOTT DAVID E I Non-Executive Director
Transaction date
Planned sale
Price
300.72
Quantity 495 -23.6%
Value US$148,856
3.0
PYOTT DAVID E I Non-Executive Director
Transaction date
Planned sale
Price
299.87
Quantity 1,222 -36.9%
Value US$366,441
3.0
PYOTT DAVID E I Non-Executive Director
Transaction date
Planned sale
Price
298.91
Quantity 1,175 -26.2%
Value US$351,219
3.0
PYOTT DAVID E I Non-Executive Director
Transaction date
Planned sale
Price
297.71
Quantity 921 -17.0%
Value US$274,191
3.0
PYOTT DAVID E I Director Non-Executive Director
Transaction date
Proposed sale
Price
299.51
Quantity 3,830
Value US$1,147,123
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
333.94
Quantity 199 -2.1%
Value US$66,454
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
331.89
Quantity 293 -2.9%
Value US$97,244
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
330.46
Quantity 829 -7.7%
Value US$273,951
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
329.76
Quantity 909 -7.8%
Value US$299,752
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
320.14
Quantity 56 -0.5%
Value US$17,928
3.0
McLaughlin Melissa Officer Officer
Transaction date
Proposed sale
Price
320.10
Quantity 2,286
Value US$731,749
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Sale
Price
325.49
Quantity 8 -0.1%
Value US$2,604
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Sale
Price
323.64
Quantity 81 -0.7%
Value US$26,215
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Sale
Price
322.86
Quantity 245 -2.0%
Value US$79,101
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Sale
Price
321.64
Quantity 224 -1.8%
Value US$72,047
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Sale
Price
320.62
Quantity 147 -1.2%
Value US$47,131
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Sale
Price
319.69
Quantity 86 -0.7%
Value US$27,493
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Sale
Price
318.47
Quantity 209 -1.6%
Value US$66,560
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Sale
Price
317.44
Quantity 359 -2.7%
Value US$113,961
3.0
McLaughlin Melissa Chief Human Resources Officer Officer
Transaction date
Sale
Price
316.61
Quantity 265 -2.0%
Value US$83,902
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Planned sale
Price
326.08
Quantity 500 -2.6%
Value US$163,040
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Planned sale
Price
324.59
Quantity 510 -2.6%
Value US$165,541
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Planned sale
Price
323.55
Quantity 740 -3.6%
Value US$239,427
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Planned sale
Price
322.33
Quantity 654 -3.1%
Value US$210,804
3.4
Fitzgerald Kevin Joseph CSO & EVP, Head of Research Officer
Transaction date
Planned sale
Price
326.24
Quantity 153 -0.7%
Value US$49,915
3.4
Fitzgerald Kevin Joseph CSO & EVP, Head of Research Officer
Transaction date
Planned sale
Price
324.60
Quantity 148 -0.7%
Value US$48,041
3.4
Fitzgerald Kevin Joseph CSO & EVP, Head of Research Officer
Transaction date
Planned sale
Price
323.25
Quantity 233 -1.1%
Value US$75,317
3.4
Fitzgerald Kevin Joseph CSO & EVP, Head of Research Officer
Transaction date
Planned sale
Price
321.81
Quantity 124 -0.6%
Value US$39,904
3.4
Garg Pushkal Officer Officer
Transaction date
Proposed sale
Price
323.69
Quantity 2,404
Value US$778,151
3.4
Fitzgerald Kevin Joseph Officer Officer
Transaction date
Proposed sale
Price
323.69
Quantity 658
Value US$212,988
3.5
Greenstreet Yvonne Chief Executive Officer Executive Director
Transaction date
Sale
Price
325.67
Quantity 265 -0.3%
Value US$86,303
3.5
Greenstreet Yvonne Chief Executive Officer Executive Director
Transaction date
Sale
Price
324.88
Quantity 345 -0.4%
Value US$112,084
3.5
Greenstreet Yvonne Chief Executive Officer Executive Director
Transaction date
Sale
Price
323.84
Quantity 973 -1.0%
Value US$315,096
3.5
Greenstreet Yvonne Chief Executive Officer Executive Director
Transaction date
Sale
Price
323.01
Quantity 444 -0.5%
Value US$143,416
3.5
Greenstreet Yvonne Chief Executive Officer Executive Director
Transaction date
Sale
Price
321.82
Quantity 368 -0.4%
Value US$118,430
3.5
Greenstreet Yvonne Chief Executive Officer Executive Director
Transaction date
Sale
Price
320.81
Quantity 274 -0.3%
Value US$87,902
3.5
Greenstreet Yvonne Chief Executive Officer Executive Director
Transaction date
Sale
Price
320.01
Quantity 129 -0.1%
Value US$41,281
3.5
Greenstreet Yvonne Chief Executive Officer Executive Director
Transaction date
Sale
Price
319.03
Quantity 135 -0.1%
Value US$43,069
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Sale
Price
325.67
Quantity 208 -1.0%
Value US$67,739
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Sale
Price
324.88
Quantity 272 -1.3%
Value US$88,367
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Sale
Price
323.84
Quantity 767 -3.4%
Value US$248,385
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Sale
Price
323.01
Quantity 350 -1.5%
Value US$113,054
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Sale
Price
321.82
Quantity 289 -1.3%
Value US$93,006
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Sale
Price
320.81
Quantity 215 -0.9%
Value US$68,974
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Sale
Price
320.01
Quantity 102 -0.4%
Value US$32,641
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Sale
Price
319.03
Quantity 106 -0.5%
Value US$33,817
3.4
Fitzgerald Kevin Joseph CSO & EVP, Head of Research Officer
Transaction date
Sale
Price
325.67
Quantity 57 -0.3%
Value US$18,563
3.4
Fitzgerald Kevin Joseph CSO & EVP, Head of Research Officer
Transaction date
Sale
Price
324.88
Quantity 75 -0.4%
Value US$24,366
3.4
Fitzgerald Kevin Joseph CSO & EVP, Head of Research Officer
Transaction date
Sale
Price
323.84
Quantity 210 -1.0%
Value US$68,006
3.4
Fitzgerald Kevin Joseph CSO & EVP, Head of Research Officer
Transaction date
Sale
Price
323.01
Quantity 96 -0.4%
Value US$31,009
3.4
Fitzgerald Kevin Joseph CSO & EVP, Head of Research Officer
Transaction date
Sale
Price
321.82
Quantity 79 -0.4%
Value US$25,424
3.4
Fitzgerald Kevin Joseph CSO & EVP, Head of Research Officer
Transaction date
Sale
Price
320.81
Quantity 59 -0.3%
Value US$18,928
3.4
Fitzgerald Kevin Joseph CSO & EVP, Head of Research Officer
Transaction date
Sale
Price
320.01
Quantity 28 -0.1%
Value US$8,960
3.4
Fitzgerald Kevin Joseph CSO & EVP, Head of Research Officer
Transaction date
Sale
Price
319.03
Quantity 29 -0.1%
Value US$9,252
3.5
Poulton Jeffrey V. EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
325.67
Quantity 223 -0.4%
Value US$72,624
3.5
Poulton Jeffrey V. EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
324.88
Quantity 291 -0.5%
Value US$94,540
3.5
Poulton Jeffrey V. EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
323.84
Quantity 818 -1.3%
Value US$264,901
3.5
Poulton Jeffrey V. EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
323.01
Quantity 374 -0.6%
Value US$120,806
3.5
Poulton Jeffrey V. EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
321.82
Quantity 309 -0.5%
Value US$99,442
3.5
Poulton Jeffrey V. EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
320.81
Quantity 230 -0.4%
Value US$73,786
3.5
Poulton Jeffrey V. EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
320.01
Quantity 109 -0.2%
Value US$34,881
3.5
Poulton Jeffrey V. EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
319.03
Quantity 114 -0.2%
Value US$36,369
3.5
Tanguler Tolga EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
325.67
Quantity 208 -0.6%
Value US$67,739
3.5
Tanguler Tolga EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
324.88
Quantity 272 -0.8%
Value US$88,367
3.5
Tanguler Tolga EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
323.84
Quantity 767 -2.2%
Value US$248,385
3.5
Tanguler Tolga EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
323.01
Quantity 350 -1.0%
Value US$113,054
3.5
Tanguler Tolga EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
321.82
Quantity 289 -0.8%
Value US$93,006
3.5
Tanguler Tolga EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
320.81
Quantity 215 -0.6%
Value US$68,974
3.5
Tanguler Tolga EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
320.01
Quantity 102 -0.3%
Value US$32,641
3.5
Tanguler Tolga EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
319.03
Quantity 106 -0.3%
Value US$33,817
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Planned sale
Price
321.50
Quantity 463 -1.9%
Value US$148,854
3.4
Garg Pushkal EVP Chief R&D Officer
Transaction date
Planned sale
Price
320.48
Quantity 640 -2.6%
Value US$205,107
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-06 2026-10-02 S Sale
SUPRAN BRYAN

EVP, CLO and Secretary

Officer
25,746 -10.2%
264.69
US$58,201 		25,746 -10.2% 264.69 US$58,201
2026-10-02 2026-10-02 PrS Proposed sale
SUPRAN BRYAN

Officer

Officer
29,670
150.87
US$1,868,728 		29,670 150.87 US$1,868,728
2026-06-03 2026-06-01 PlS Planned sale
3.0
PYOTT DAVID E I
Non-Executive Director
7,156 -10.0%
35.03
US$3,787,316 		7,156 -10.0% 35.03 US$3,787,316
2026-06-03 2026-06-01 PlS Planned sale
3.0
PYOTT DAVID E I
Non-Executive Director
495 -23.6%
300.72
US$148,856 		495 -23.6% 300.72 US$148,856
2026-06-03 2026-06-01 PlS Planned sale
3.0
PYOTT DAVID E I
Non-Executive Director
1,222 -36.9%
299.87
US$366,441 		1,222 -36.9% 299.87 US$366,441
2026-06-03 2026-06-01 PlS Planned sale
3.0
PYOTT DAVID E I
Non-Executive Director
1,175 -26.2%
298.91
US$351,219 		1,175 -26.2% 298.91 US$351,219
2026-06-03 2026-06-01 PlS Planned sale
3.0
PYOTT DAVID E I
Non-Executive Director
921 -17.0%
297.71
US$274,191 		921 -17.0% 297.71 US$274,191
2026-06-01 2026-06-01 PrS Proposed sale
3.0
PYOTT DAVID E I

Director

Non-Executive Director
3,830
299.51
US$1,147,123 		3,830 299.51 US$1,147,123
2026-04-07 2026-04-06 PlS Planned sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
199 -2.1%
333.94
US$66,454 		199 -2.1% 333.94 US$66,454
2026-04-07 2026-04-06 PlS Planned sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
293 -2.9%
331.89
US$97,244 		293 -2.9% 331.89 US$97,244
2026-04-07 2026-04-06 PlS Planned sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
829 -7.7%
330.46
US$273,951 		829 -7.7% 330.46 US$273,951
2026-04-07 2026-04-06 PlS Planned sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
909 -7.8%
329.76
US$299,752 		909 -7.8% 329.76 US$299,752
2026-04-07 2026-04-06 PlS Planned sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
56 -0.5%
320.14
US$17,928 		56 -0.5% 320.14 US$17,928
2026-04-06 2026-04-06 PrS Proposed sale
3.0
McLaughlin Melissa

Officer

Officer
2,286
320.10
US$731,749 		2,286 320.10 US$731,749
2026-04-07 2026-04-02 S Sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
8 -0.1%
325.49
US$2,604 		8 -0.1% 325.49 US$2,604
2026-04-07 2026-04-02 S Sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
81 -0.7%
323.64
US$26,215 		81 -0.7% 323.64 US$26,215
2026-04-07 2026-04-02 S Sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
245 -2.0%
322.86
US$79,101 		245 -2.0% 322.86 US$79,101
2026-04-07 2026-04-02 S Sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
224 -1.8%
321.64
US$72,047 		224 -1.8% 321.64 US$72,047
2026-04-07 2026-04-02 S Sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
147 -1.2%
320.62
US$47,131 		147 -1.2% 320.62 US$47,131
2026-04-07 2026-04-02 S Sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
86 -0.7%
319.69
US$27,493 		86 -0.7% 319.69 US$27,493
2026-04-07 2026-04-02 S Sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
209 -1.6%
318.47
US$66,560 		209 -1.6% 318.47 US$66,560
2026-04-07 2026-04-02 S Sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
359 -2.7%
317.44
US$113,961 		359 -2.7% 317.44 US$113,961
2026-04-07 2026-04-02 S Sale
3.0
McLaughlin Melissa

Chief Human Resources Officer

Officer
265 -2.0%
316.61
US$83,902 		265 -2.0% 316.61 US$83,902
2026-03-06 2026-03-05 PlS Planned sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
500 -2.6%
326.08
US$163,040 		500 -2.6% 326.08 US$163,040
2026-03-06 2026-03-05 PlS Planned sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
510 -2.6%
324.59
US$165,541 		510 -2.6% 324.59 US$165,541
2026-03-06 2026-03-05 PlS Planned sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
740 -3.6%
323.55
US$239,427 		740 -3.6% 323.55 US$239,427
2026-03-06 2026-03-05 PlS Planned sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
654 -3.1%
322.33
US$210,804 		654 -3.1% 322.33 US$210,804
2026-03-06 2026-03-05 PlS Planned sale
3.4
Fitzgerald Kevin Joseph

CSO & EVP, Head of Research

Officer
153 -0.7%
326.24
US$49,915 		153 -0.7% 326.24 US$49,915
2026-03-06 2026-03-05 PlS Planned sale
3.4
Fitzgerald Kevin Joseph

CSO & EVP, Head of Research

Officer
148 -0.7%
324.60
US$48,041 		148 -0.7% 324.60 US$48,041
2026-03-06 2026-03-05 PlS Planned sale
3.4
Fitzgerald Kevin Joseph

CSO & EVP, Head of Research

Officer
233 -1.1%
323.25
US$75,317 		233 -1.1% 323.25 US$75,317
2026-03-06 2026-03-05 PlS Planned sale
3.4
Fitzgerald Kevin Joseph

CSO & EVP, Head of Research

Officer
124 -0.6%
321.81
US$39,904 		124 -0.6% 321.81 US$39,904
2026-03-05 2026-03-05 PrS Proposed sale
3.4
Garg Pushkal

Officer

Officer
2,404
323.69
US$778,151 		2,404 323.69 US$778,151
2026-03-05 2026-03-05 PrS Proposed sale
3.4
Fitzgerald Kevin Joseph

Officer

Officer
658
323.69
US$212,988 		658 323.69 US$212,988
2026-03-06 2026-03-04 S Sale
3.5
Greenstreet Yvonne

Chief Executive Officer

Executive Director
265 -0.3%
325.67
US$86,303 		265 -0.3% 325.67 US$86,303
2026-03-06 2026-03-04 S Sale
3.5
Greenstreet Yvonne

Chief Executive Officer

Executive Director
345 -0.4%
324.88
US$112,084 		345 -0.4% 324.88 US$112,084
2026-03-06 2026-03-04 S Sale
3.5
Greenstreet Yvonne

Chief Executive Officer

Executive Director
973 -1.0%
323.84
US$315,096 		973 -1.0% 323.84 US$315,096
2026-03-06 2026-03-04 S Sale
3.5
Greenstreet Yvonne

Chief Executive Officer

Executive Director
444 -0.5%
323.01
US$143,416 		444 -0.5% 323.01 US$143,416
2026-03-06 2026-03-04 S Sale
3.5
Greenstreet Yvonne

Chief Executive Officer

Executive Director
368 -0.4%
321.82
US$118,430 		368 -0.4% 321.82 US$118,430
2026-03-06 2026-03-04 S Sale
3.5
Greenstreet Yvonne

Chief Executive Officer

Executive Director
274 -0.3%
320.81
US$87,902 		274 -0.3% 320.81 US$87,902
2026-03-06 2026-03-04 S Sale
3.5
Greenstreet Yvonne

Chief Executive Officer

Executive Director
129 -0.1%
320.01
US$41,281 		129 -0.1% 320.01 US$41,281
2026-03-06 2026-03-04 S Sale
3.5
Greenstreet Yvonne

Chief Executive Officer

Executive Director
135 -0.1%
319.03
US$43,069 		135 -0.1% 319.03 US$43,069
2026-03-06 2026-03-04 S Sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
208 -1.0%
325.67
US$67,739 		208 -1.0% 325.67 US$67,739
2026-03-06 2026-03-04 S Sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
272 -1.3%
324.88
US$88,367 		272 -1.3% 324.88 US$88,367
2026-03-06 2026-03-04 S Sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
767 -3.4%
323.84
US$248,385 		767 -3.4% 323.84 US$248,385
2026-03-06 2026-03-04 S Sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
350 -1.5%
323.01
US$113,054 		350 -1.5% 323.01 US$113,054
2026-03-06 2026-03-04 S Sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
289 -1.3%
321.82
US$93,006 		289 -1.3% 321.82 US$93,006
2026-03-06 2026-03-04 S Sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
215 -0.9%
320.81
US$68,974 		215 -0.9% 320.81 US$68,974
2026-03-06 2026-03-04 S Sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
102 -0.4%
320.01
US$32,641 		102 -0.4% 320.01 US$32,641
2026-03-06 2026-03-04 S Sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
106 -0.5%
319.03
US$33,817 		106 -0.5% 319.03 US$33,817
2026-03-06 2026-03-04 S Sale
3.4
Fitzgerald Kevin Joseph

CSO & EVP, Head of Research

Officer
57 -0.3%
325.67
US$18,563 		57 -0.3% 325.67 US$18,563
2026-03-06 2026-03-04 S Sale
3.4
Fitzgerald Kevin Joseph

CSO & EVP, Head of Research

Officer
75 -0.4%
324.88
US$24,366 		75 -0.4% 324.88 US$24,366
2026-03-06 2026-03-04 S Sale
3.4
Fitzgerald Kevin Joseph

CSO & EVP, Head of Research

Officer
210 -1.0%
323.84
US$68,006 		210 -1.0% 323.84 US$68,006
2026-03-06 2026-03-04 S Sale
3.4
Fitzgerald Kevin Joseph

CSO & EVP, Head of Research

Officer
96 -0.4%
323.01
US$31,009 		96 -0.4% 323.01 US$31,009
2026-03-06 2026-03-04 S Sale
3.4
Fitzgerald Kevin Joseph

CSO & EVP, Head of Research

Officer
79 -0.4%
321.82
US$25,424 		79 -0.4% 321.82 US$25,424
2026-03-06 2026-03-04 S Sale
3.4
Fitzgerald Kevin Joseph

CSO & EVP, Head of Research

Officer
59 -0.3%
320.81
US$18,928 		59 -0.3% 320.81 US$18,928
2026-03-06 2026-03-04 S Sale
3.4
Fitzgerald Kevin Joseph

CSO & EVP, Head of Research

Officer
28 -0.1%
320.01
US$8,960 		28 -0.1% 320.01 US$8,960
2026-03-06 2026-03-04 S Sale
3.4
Fitzgerald Kevin Joseph

CSO & EVP, Head of Research

Officer
29 -0.1%
319.03
US$9,252 		29 -0.1% 319.03 US$9,252
2026-03-06 2026-03-04 S Sale
3.5
Poulton Jeffrey V.

EVP, Chief Financial Officer

Officer
223 -0.4%
325.67
US$72,624 		223 -0.4% 325.67 US$72,624
2026-03-06 2026-03-04 S Sale
3.5
Poulton Jeffrey V.

EVP, Chief Financial Officer

Officer
291 -0.5%
324.88
US$94,540 		291 -0.5% 324.88 US$94,540
2026-03-06 2026-03-04 S Sale
3.5
Poulton Jeffrey V.

EVP, Chief Financial Officer

Officer
818 -1.3%
323.84
US$264,901 		818 -1.3% 323.84 US$264,901
2026-03-06 2026-03-04 S Sale
3.5
Poulton Jeffrey V.

EVP, Chief Financial Officer

Officer
374 -0.6%
323.01
US$120,806 		374 -0.6% 323.01 US$120,806
2026-03-06 2026-03-04 S Sale
3.5
Poulton Jeffrey V.

EVP, Chief Financial Officer

Officer
309 -0.5%
321.82
US$99,442 		309 -0.5% 321.82 US$99,442
2026-03-06 2026-03-04 S Sale
3.5
Poulton Jeffrey V.

EVP, Chief Financial Officer

Officer
230 -0.4%
320.81
US$73,786 		230 -0.4% 320.81 US$73,786
2026-03-06 2026-03-04 S Sale
3.5
Poulton Jeffrey V.

EVP, Chief Financial Officer

Officer
109 -0.2%
320.01
US$34,881 		109 -0.2% 320.01 US$34,881
2026-03-06 2026-03-04 S Sale
3.5
Poulton Jeffrey V.

EVP, Chief Financial Officer

Officer
114 -0.2%
319.03
US$36,369 		114 -0.2% 319.03 US$36,369
2026-03-06 2026-03-04 S Sale
3.5
Tanguler Tolga

EVP, Chief Commercial Officer

Officer
208 -0.6%
325.67
US$67,739 		208 -0.6% 325.67 US$67,739
2026-03-06 2026-03-04 S Sale
3.5
Tanguler Tolga

EVP, Chief Commercial Officer

Officer
272 -0.8%
324.88
US$88,367 		272 -0.8% 324.88 US$88,367
2026-03-06 2026-03-04 S Sale
3.5
Tanguler Tolga

EVP, Chief Commercial Officer

Officer
767 -2.2%
323.84
US$248,385 		767 -2.2% 323.84 US$248,385
2026-03-06 2026-03-04 S Sale
3.5
Tanguler Tolga

EVP, Chief Commercial Officer

Officer
350 -1.0%
323.01
US$113,054 		350 -1.0% 323.01 US$113,054
2026-03-06 2026-03-04 S Sale
3.5
Tanguler Tolga

EVP, Chief Commercial Officer

Officer
289 -0.8%
321.82
US$93,006 		289 -0.8% 321.82 US$93,006
2026-03-06 2026-03-04 S Sale
3.5
Tanguler Tolga

EVP, Chief Commercial Officer

Officer
215 -0.6%
320.81
US$68,974 		215 -0.6% 320.81 US$68,974
2026-03-06 2026-03-04 S Sale
3.5
Tanguler Tolga

EVP, Chief Commercial Officer

Officer
102 -0.3%
320.01
US$32,641 		102 -0.3% 320.01 US$32,641
2026-03-06 2026-03-04 S Sale
3.5
Tanguler Tolga

EVP, Chief Commercial Officer

Officer
106 -0.3%
319.03
US$33,817 		106 -0.3% 319.03 US$33,817
2026-03-04 2026-03-03 PlS Planned sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
463 -1.9%
321.50
US$148,854 		463 -1.9% 321.50 US$148,854
2026-03-04 2026-03-03 PlS Planned sale
3.4
Garg Pushkal

EVP Chief R&D

Officer
640 -2.6%
320.48
US$205,107 		640 -2.6% 320.48 US$205,107

See older Alnylam Pharmaceuticals Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Alnylam Pharmaceuticals Inc history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Alnylam Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America